Author

Rongchen Liu

Chinese Academy of SciencesPrimary ORCID profile (0009-0005-8210-697X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Rongchen LiuiD1 paper · Lianyungang Normal College

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Fanglin LiiD· 2 shared Fengru Qiu· 2 shared Fengyu DuiD· 2 shared Likun GongiD· 2 shared Liying CheniD· 2 shared Runqiu CheniD· 2 shared Shanna Wu· 2 shared Xinhang ZhengiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Fanglin LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

STING agonist-mediated endothelial cell activation drives NK cells and neutrophils-dependent pulmonary inflammation

Chen Chen, Yaqi Zhao, Fengyu Du, Rongchen Liu, Xinhang Zheng, Shanna Wu, Yiting Wang, Fengru Qiu, Liying Chen, Runqiu Chen, Fanglin Li, Likun Gong, Yiru Long

This study identifies the endothelial cell-NK cell-neutrophil axis as a key driver of STING agonist-induced pulmonary inflammation and toxicity.

bioRxiv · Mar 12, 2026 · PreprintPharmacology & Toxicology

CTLA-4 inhibitors drive colitis through metabolic reprogramming-mediated Treg/Th17 imbalance

Zhiying Li, Shanna Wu, Rongchen Liu, Runqiu Chen, Fanglin Li, Rong Zhang, Yiting Wang, Chaoqi Chen, Xinhang Zheng, Fengru Qiu, Liying Chen, Yaqi Zhao, Fengyu Du, Likun Gong, Yiru Long

This study identifies metabolic reprogramming as a mechanism by which CTLA-4 inhibitors cause colitis, showing that metformin can alleviate this toxicity without affecting antitumor efficacy.

bioRxiv · Jan 21, 2026 · PreprintPharmacology & Toxicology